Target intelligence / Profile preview

Eukaryotic translation termination factor 1 pseudogene 3 (ETF1P3)

Target: ETF1P3
Molecular classification: Other (pseudogene)

Overview

Eukaryotic translation termination factor 1 pseudogene 3 (ETF1P3) is classified as a pseudogene, meaning it is a segment of DNA that resembles a gene but does not produce a functional protein[1]. It is homologous to the ETF1 gene, which encodes a key factor involved in translation termination during protein synthesis, but ETF1P3 itself is not expressed as a protein and has no known functional role or relevance in therapeutic targeting[1]. There is no evidence for its utility as a drug target, biomarker, or disease-linked gene.

Other names: D5S1995TB3-1

Beyond the preview

Go deeper on Eukaryotic translation termination factor 1 pseudogene 3 (ETF1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation termination factor 1 pseudogene 3 (ETF1P3).

Explore the full profile